Navigation Links
Simple Stroke Prevention is Best

Aspirin appears to be a better treatment than the antiplatelet drug ticlopidine for preventing recurrent strokes in black patients, according to new research in this week’s issue of the Journal of the American Medical Association. The study included 1,809 black men and women who recently had strokes that were not due to bleeding in the brain or to blockage of a blood vessel in the brain. Participants received either a daily 500-milligram dose of ticlopidine or a daily 650-milligram dose of aspirin.//
Researchers hypothesized ticlopidine would be more effective in black ischemic stroke patients than aspirin. The study was halted after 6.5 years when researchers found the exact opposite. In fact, study results suggest a 40-percent to 50-percent likelihood of aspirin being significantly better in reducing stroke risk if the study were to continue to completion. Investigators conclude, "Aspirin is much less expensive than other major antiplatelet agents, is readily available, easy to use, and relatively safe."

Blacks are about twice as likely as most other individuals in the United States to die from or experience stroke. In an accompanying editorial, Ralph Sacco, M.S., M.D., from New York Presbyterian Hospital, says, "The study provides new data on an alternate antiplatelet agent (ticlopidine) that should no longer be recommended for prevention of recurrent stroke -- certainly not in black patients."
'"/>




Page: 1

Related medicine news :

1. Long-Term Survival can be Predicted by a Simple Lung Test
2. Simple Therapy
3. Few Simple Steps to Lower The Incidence Of SIDS
4. A Simple Blood Test Can Predict Gum Disease
5. A Simple Exercise Can Uncover Undiagnosed Asthma
6. Simple Exercises Might Help Vertigo
7. Simple Steps To Help Fight Asthma
8. Simple Urine Test Can Help To Monitor Disfiguring Birthmarks
9. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
10. Simple Procedural Improvements Can Improve Care Of Stroke Patients
11. Simplest therapeutic regimen found less effective against HIV
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... LYNDHURST, N.J. (PRWEB) , ... September 17, 2019 ... ... in a wide array of services, welcomes Dr. Yevgeniya (Jenny) Gartshteyn to their ... University Medical Center, where she previously held the Clinical Appointment of Assistant Professor ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... detection and treatment of infectious diseases at its annual Congress (WMIC) recently ... detection of residual HIV infected cell persistence and the development of pathogen-specific ...
(Date:9/12/2019)... Ohio (PRWEB) , ... September 12, 2019 , ... ... on both a local and national scale in two recent and well-renowned listing ... country’s fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey ...
(Date:9/11/2019)... ... 11, 2019 , ... Workplace injuries cost individuals, organisations and ... risks which lead to musculoskeletal disorders (MSDs). , Starting with the individual ... at Soter Analytics helps avoid ergonomic injury by coaching workers to ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... accredited continuing medical education (CME) provider, is the official accreditor for PAINWeek, the ... vetted speakers, and screened topics, as it has done for the past ten ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... 13, 2019 , ... Corey Stern , a partner at Levy Konigsberg, ... Archibald over at least 3 decades while employed by Rockefeller University Hospital (“RUH”). ... Court - Southern District of New York, No. 1:19-cv-01403), the first case filed against ...
(Date:9/14/2019)... N.J. (PRWEB) , ... September 14, 2019 , ... ... trial of four plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County ... first consolidated trial of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J ...
(Date:9/11/2019)... China (PRWEB) , ... September ... ... Co., Ltd.“Jiuzhou Pharmaceutical, a world leading Active Pharmaceutical Ingredients (API) contract development ... commitment for the purchase of Suzhou Novartis Pharmaceutical Technology Ltd (SNPT), an ...
Breaking Medicine Technology: